About Event
Returning for its 7th year, the Chronic Kidney Disease Drug Development Summit (CKD3) was the definitive forum for advancing innovation in kidney health, uniting over 180 global experts spanning discovery, preclinical, translational, clinical, and regulatory fields.
As the CKD landscape celebrates major milestones like Novartis' Borealis Biosciences launch, IgAN approval, and transformative acquisitions by Biogen, Vertex, and Apellis, the field stands at the forefront of a Kidney Renaissance. With the FDA’s increasing support for accelerated approval pathways and a surge of new therapies targeting both rare and common kidney diseases, the CKD3 Summit provided a pivotal opportunity to shape the future of renal drug development.
Discover Breakthrough Therapies
Attendees delved into how game-changing advancements like SGLT2i, GLP-1s, and MRAs are reshaping CKD care with insights from AstraZeneca, Sanofi, Bayer, and Eli Lilly. They understood their impact on drug discovery, development, and clinical trial design to keep pace with the evolving treatment paradigm.
Advance Precision Medicine in CKD
We heard from leaders like Matthias Kretzler and Bayer as they explore cutting-edge strategies for translating genetic and molecular insights into clinical practice, tailoring treatments to diverse CKD subpopulations, and advancing personalized care.
Unlock Opportunities in Glomerular Diseases
Attendees joined Jonathan Barratt, Calliditas, and Travere Therapeutics to examine breakthroughs in glomerular diseases beyond IgA nephropathy, addressing FSGS, lupus nephritis, C3G, and membranous nephropathy, and identify paths to improve patient outcomes.
Dive Into Next-Generation CKD Workshops
We engaged in discussion-based workshops tackling the biggest challenges in CKD drug development, from leveraging omics and real-world data for target discovery to advancing pediatric nephrology and mastering hierarchical composite endpoints with Alexion, Boehringer Ingelheim, and more.
Join us in March 2026 to shape the future of kidney care in the transformative era of renal drug development!
What You Missed:
180+ Global Attendees from Across the Renal Landscape
40+ Expert Speakers with Unique Insights
10+ Hours of Face-to-Face Networking Opportunities
3 Days of Unmissable Data-Driven Content
2 Dedicate Tracks of Content for the Whole Team
1 Brand-New Focus Day Dedicated to Glomerular Disease
3 Unmissable Deep Dive Workshops with Industry Leaders
The CKD Drug Development Summit is quickly becoming one of the must-attend meetings on the nephrology industry calendar, hear what our past attendees have to say:
